Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. DEF 14A Proxy Proxy Statement
  2. DEFA14A Proxy Proxy Materials
  3. UPLOAD Other SEC-generated Letter
  4. S-3 Offering Registration Statement
  5. 8-K Event Change in control
  6. 10-K Report Annual Report
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event Material agreement
  13. 424B5 Offering Prospectus
  14. 424B5 Offering Prospectus
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 424B5 Offering Prospectus
  17. SC 13G Stake Amended Statement of Ownership
  18. EFFECT Other Notice of Effectiveness
  19. 424B3 Offering Prospectus
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 12 of 80 · 1,583 filings